Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription

Lin Zou1, Penghui Zhang, Chunli Luo

  • 1Faculty of Laboratory Medicine at Chongqing University of Medical Sciences, Key Laboratory of Laboratory Medical Diagnosis of Education Ministry, Chongqing, China.

Urology
|June 13, 2006
PubMed
Abstract

Insights

Mitosis arrest deficiency 1 (Mad1) inhibits bladder cancer cell proliferation by suppressing human telomerase reverse transcriptase (hTERT) transcription and telomerase activity. Mad1 shows potential for bladder cancer growth inhibition.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Bladder cancer remains a significant health concern.
  • Understanding novel therapeutic targets is crucial for effective treatment.

Purpose of the Study:

  • To investigate the effects of Mad1 on bladder cancer cell proliferation.
  • To elucidate the underlying mechanisms involving hTERT and telomerase activity.

Main Methods:

  • Utilized MTT assay, flow cytometry, and luciferase assays.
  • Assessed hTERT expression and telomerase activity via TRAP-ELISA and qRT-PCR.
  • Evaluated effects in vitro (T24, EJ cells) and in vivo (xenograft models).

Main Results:

  • Mad1 significantly inhibited bladder cancer cell proliferation.
  • Mad1 induced G0/G1 cell cycle arrest.
  • Mad1 downregulated hTERT transcription, expression, and telomerase activity in cells and tumors.

Conclusions:

  • Mad1 inhibits bladder cancer growth by targeting hTERT transcription and telomerase activity.
  • Mad1 presents a potential therapeutic candidate for bladder cancer treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...